Vimarsana
Biggest News Aggregation in the World

Page 2 - Acticor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acticor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acticor Today - Breaking & Trending Today

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of January 31, 2023 - Vimarsana News

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of January 31, 2023

Published: February 8, 2023

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies

Source: finanznachrichten.de
Related Topics:
France GeneralNewton BiocapitalSchwierige ZeitenVenture InvestmentFrench National Institute Of HealthRegulation Of The French Financial Markets AuthorityEuropean Medicines AgencyRegulatory NewsFrench Commercial CodeGeneral RegulationFrench Financial Markets AuthorityEuronext Growth ParisFrench National InstituteMedical ResearchActicor BiotechMirae Asset CapitalPrimer Capital
Acticor Biotech: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux - Vimarsana News

Acticor Biotech: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux

Published: January 6, 2023

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies

Source: finanznachrichten.de
Related Topics:
France GeneralNewton BiocapitalKepler CheuvreuxVenture InvestmentFrench National Institute Of HealthEuropean Medicines AgencyRegulatory NewsFrench National InstituteMedical ResearchActicor BiotechMirae Asset CapitalPrimer CapitalEuronext Growth Paris
Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2022 - Vimarsana News

Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2022

Published: January 6, 2023

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies

Source: finanznachrichten.de
Related Topics:
France GeneralNewton BiocapitalVenture InvestmentFrench National Institute Of HealthRegulation Of The French Financial Markets AuthorityEuropean Medicines AgencyRegulatory NewsFrench Commercial CodeGeneral RegulationFrench Financial Markets AuthorityEuronext Growth ParisFrench National InstituteMedical ResearchActicor BiotechMirae Asset CapitalPrimer Capital
Acticor Biotech Provides an Update on the Us Regulatory Discussion with the FDA - Vimarsana News

Acticor Biotech Provides an Update on the Us Regulatory Discussion with the FDA

Published: December 23, 2022

Regulatory News: Acticor Biotech, (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular

Source: finanznachrichten.de
Related Topics:
United StatesFrance GeneralNewton BiocapitalGilles AvenardVenture InvestmentFrench National Institute Of HealthEuropean Medicines AgencyEuropean AgencyRegulatory NewsActicor BiotechBiologic License ApplicationFast TrackChief Executive OfficerFrench National InstituteMedical ResearchMirae Asset CapitalPrimer CapitalMediolanum FarmaceuticiEuronext Growth Paris
Acticor Biotech Announces Its Financial Agenda for The 1st Half of 2023 - Vimarsana News

Acticor Biotech Announces Its Financial Agenda for The 1st Half of 2023

Published: December 1, 2022

Regulatory News: Acticor Biotech (Euronext Growth Paris ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical-stage biopharmaceutical company, a spin-off of INSERM, developing an innovative drug for

Source: finanznachrichten.de
Related Topics:
France GeneralNewton BiocapitalVenture InvestmentFrench National Institute Of HealthEuropean Medicines AgencyRegulatory NewsEuronext Growth ParisFrench National InstituteMedical ResearchActicor BiotechMirae Asset CapitalPrimer Capital